Tag Archives: Bayer v Lupin

Bayer v. Lupin – Patenting The Label Redux

In my post of January 13, 2011, I discussed AstraZeneca LP v. Apotex, a Fed. Cir. decision in which AZ argued successfully that the proposed  Apotex labeling for an anti-asthma drug would induce infringement if the generic were marketed with … Continue reading

Posted in Hatch-Waxman | Tagged , , , , , , , , , , , | Leave a comment